Acne is primarily a disease of the pilosebaceous unit. Androgens (male hormones present in all women, including testosterone and DHEA-S) stimulate the sebaceous glands to produce more sebum. Excess sebum, combined with dead skin cells and Cutibacterium acnes bacteria, blocks pores and triggers inflammation.
Even women with "normal" androgen blood levels can have skin that's hyper-responsive to these hormones at the receptor level — this is called peripheral androgen sensitivity. The Cochrane review of oral contraceptives for acne (Arowojolu et al., 2012) found that combined oral contraceptives consistently reduced acne lesion counts and severity compared to placebo.
Combined oral contraceptive pills contain synthetic oestrogen (typically ethinyl estradiol) and a progestogen. They work through two main mechanisms:
One of the longest-studied pills for hormonal acne. Cyproterone acetate is a potent anti-androgen that blocks androgen receptors and reduces adrenal androgen production. Studies show reductions in sebum excretion rate and acne lesion counts within 3–6 months (van Vloten et al., 2002). Note: slightly higher VTE (venous thromboembolism) risk vs levonorgestrel-containing pills — discuss with your doctor.
Yasmin (ethinyl estradiol 30mcg + drospirenone 3mg) and Yaz (20mcg + drospirenone 3mg) are widely prescribed in Singapore for hormonal acne. The American Academy of Dermatology (AAD) lists combined oral contraceptives as a Level A recommendation for moderate-to-severe inflammatory acne in women who also want contraception (Zaenglein et al., JAAD, 2016).
The pill treats acne while you're taking it. Acne may return after stopping, though some women find lasting improvement.
The pill as an acne treatment is appropriate for women who have moderate-to-severe hormonal acne (particularly jawline, chin, cyclical), who also want reliable contraception, are non-smokers under 35, and have no contraindications to oestrogen.
In Singapore, combined oral contraceptives require a prescription from a licensed doctor. When you consult, mention that your acne is hormonal in pattern (cyclical, jawline/chin), that you're interested in a pill with anti-androgenic activity, and list any pills you've previously tried.
Zoey connects you with Singapore-registered doctors for a confidential online consultation — no waiting room, fast prescription and delivery.
Will any birth control pill help acne?
Not equally. Pills with anti-androgenic progestins (drospirenone, cyproterone acetate) tend to be most effective. Pills with androgenic progestins may not improve acne.
How long before I see results?
Most women see meaningful improvement by month 3, with peak effect at 6 months. Give it at least 3–4 cycles before concluding it's not working.
Can I take the pill just for acne, not for contraception?
In Singapore, yes — a doctor can prescribe off-label for hormonal acne. The decision is clinical and based on your health history.
What if I stop taking the pill?
Acne may return. Some women find improvement persists; others see a gradual return within months of stopping.
Is the pill safe long-term?
For most healthy, non-smoking women under 35, long-term use is considered safe. Annual reviews with your doctor are recommended.
Zoey is a licensed telehealth platform for women's health in Singapore. All prescriptions are issued by MOH-registered doctors.

Articles featured on Zoey are for informational purposes only and should not be constituted as medical advice, diagnosis or treatment. If you have any medical questions or concerns, please talk to your healthcare provider. If you're looking for a healthcare provider, click here.
Arowojolu AO et al. "Combined oral contraceptive pills for treatment of acne." Cochrane Database of Systematic Reviews. 2012;7:CD004425.
van Vloten WA et al. "The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea." Dermatology. 2002;205(3):250–255.
Lucky AW et al. "A combined oral contraceptive containing 3-mg drospirenone/20-μg ethinyl estradiol in the treatment of acne vulgaris." Journal of Drugs in Dermatology. 2008;7(9):898–904.
Zaenglein AL et al. "Guidelines of care for the management of acne vulgaris." JAAD. 2016;74(5):945–973.